Dr. Reddy’s Q2 Review: Systematix Maintains ‘Hold’ Post Inline Results
Dr. Reddy’s Laboratories Ltd.’s Q2 FY26 earnings were inline with estimates. Revenue and PAT grew 10% and 6% YoY respectively. Systematix maintains ‘Hold’ post inline results.
Dr. Reddy’s Laboratories Ltd.’s Q2 FY26 earnings were inline with estimates. Revenue and PAT grew 10% and 6% YoY respectively. Systematix maintains ‘Hold’ post inline results.
The recent surge in Singapore’s gross refining margins has significant implications for Indian refiners. Find out how this development can impact major Indian refiners and the overall oil and gas sector.
The Nifty 50 and Sensex continued to gain after rebounding at open, with SBI Life Insurance Co, Reliance Industries Ltd., and Tata Steel Ltd. shares being top gainers in the Nifty 50 index. Get the latest updates from the Indian stock markets.
Foreign portfolio investors (FPIs) turned net sellers of Indian shares after four sessions, offloading equities worth Rs 1,165.94 crore. Understand the implications on the Indian stock market and Nifty levels.
US yields climb as oil prices surge ahead of key inflation data, while stocks rise amid solid earnings. What does this mean for Indian investors and the global market outlook?
Get the latest Q2 results updates from Indian companies, including Colgate Palmolive, HUL, Bharti Airtel, Sagar Cements, and PTC India Financial Services, and understand their impact on the stock market.
Get the latest updates on the Indian stock market, including stocks to watch, Q2 results, and major corporate actions affecting investor sentiment.
Over 25 Indian companies, including Coforge, ITC Hotels, Dr Reddy’s, and SBI Cards, are set to announce their Q2FY26 results on Oct 24. Find out what to expect from these major earnings reports.
Colgate-Palmolive (India) Ltd. reported a 17% year-on-year decline in net profit to Rs 327.50 crore for the quarter ended September, prompting brokerages to revise their target prices.
HUL’s Q2 review indicates constructive macro drivers and rising expectations for H2, with a focus on volume acceleration and new launches.